Holmusk and Otsuka team up to develop real-world evidence based behavioural health platform. CONTEXT: Commercial announcement that Holmusk and Otsuka are partnering to develop one of the largest real-world evidence Continue Reading
ALK present results of huge real-world evidence study on allergy immunotherapy (AIT) in asthma CONTEXT: ALK presented the results on the long term effects of allergy immunotherapy (AIT) on asthma Continue Reading
Real-world research papers presented at the American Diabetes Association annual meeting. CONTEXT: The Annual meeting of the American Diabetes Association held virtually this year attracted more than 11,500 participants. Just Continue Reading
Rising prevalence of depression and anxiety are major drivers in the increased demand for psychedelic drugs CONTEXT: This article reviews the increasing demand for psychedelic drugs in the treatment of Continue Reading
Real-World research study reveals less than half of NSCLC patients receive comprehensive biomarker testing prior to receiving 1st line therapy. CONTEXT: A retrospective chart review of metastatic NSCLC patients presented Continue Reading
The role of family health history in predicting midlife chronic disease outcomes. CONTEXT: This longitudinal real-world research study published in the American Journal of Preventive Medicine looked at the relevance Continue Reading
Associations between hip joint space width and osteoarthritis, a community based cohort study. CONTEXT: Real-world research published in Arthritis Care Res looked at 397 US osteoarthritis (OA) patients to look Continue Reading
Journal of the Association of Physicians in India (JAPI) looks at real-world use of Nimesulide in treating acute febrile illness CONTEXT: Research published in the Journal of the Association of Continue Reading
Cures 2.0 – Details of what’s in store for Real-World Evidence CONTEXT: This article provides a nice summary and a bit more detail on the draft legislation that will eventually Continue Reading
Canadian COVID vaccine study concludes Pfizer, Moderna and AZ all provide good protection against variants of concern. CONTEXT: Real-world research study in Canada using vaccination, laboratory testing and health administration Continue Reading
